SHEL.UK

2,874.5

-0.1%↓

SHEL.UK

2,874.5

-0.1%↓

SHEL.UK

2,874.5

-0.1%↓

SHEL.UK

2,874.5

-0.1%↓

SHEL.UK

2,874.5

-0.1%↓

Search

DCC PLC

Atidarymo kaina

SektoriusEnergijos sektorius

5,250 0.1

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5180

Max

5260

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-116M

-4.1M

Pardavimai

-1.3B

7.4B

P/E

Sektoriaus vid.

37.674

25.238

Pelnas, tenkantis vienai akcijai

1.3

Dividendų pajamingumas

4.29

Pelno marža

-0.056

Darbuotojai

16,700

EBITDA

-113M

260M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+8.55% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.29%

4.00%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-700M

4.2B

Ankstesnė atidarymo kaina

5249.9

Ankstesnė uždarymo kaina

5250

Naujienos nuotaikos

By Acuity

50%

50%

55 / 137 reitingas Energy

DCC PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-15 23:21; UTC

Įsigijimai, susijungimai, perėmimai

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

2026-02-15 23:45; UTC

Rinkos pokalbiai

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

2026-02-15 23:40; UTC

Rinkos pokalbiai

Gold Falls on Possible Position Adjustments -- Market Talk

2026-02-15 23:06; UTC

Uždarbis

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

2026-02-15 23:04; UTC

Uždarbis

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

2026-02-15 23:04; UTC

Uždarbis

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

2026-02-15 23:01; UTC

Uždarbis

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

2026-02-15 23:01; UTC

Uždarbis

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

2026-02-15 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

2026-02-15 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

2026-02-15 22:52; UTC

Įsigijimai, susijungimai, perėmimai

Qube Shareholders to Receive A$5.20/Share in Cash

2026-02-15 22:52; UTC

Įsigijimai, susijungimai, perėmimai

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

2026-02-15 22:22; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO Tania Archibald Speaking on a Call With Media

2026-02-15 22:17; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

2026-02-15 22:16; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

2026-02-15 22:14; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

2026-02-15 22:14; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

2026-02-15 20:48; UTC

Uždarbis

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

2026-02-15 20:47; UTC

Uždarbis

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

2026-02-15 20:46; UTC

Uždarbis

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

2026-02-15 20:45; UTC

Uždarbis

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

2026-02-15 20:44; UTC

Uždarbis

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

2026-02-15 20:44; UTC

Uždarbis

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

2026-02-15 20:43; UTC

Uždarbis

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

2026-02-15 20:42; UTC

Uždarbis

BlueScope Net Debt A$2.2 Million at Dec. 31

2026-02-15 20:42; UTC

Uždarbis

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

2026-02-15 20:41; UTC

Uždarbis

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

2026-02-15 20:40; UTC

Uždarbis

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

2026-02-15 20:40; UTC

Uždarbis

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

2026-02-15 20:39; UTC

Uždarbis

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Akcijų palyginimas

Kainos pokytis

DCC PLC Prognozė

Kainos tikslas

By TipRanks

8.55% į viršų

12 mėnesių prognozė

Vidutinis 5,731.6 GBX  8.55%

Aukščiausias 6,500 GBX

Žemiausias 4,708 GBX

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines DCC PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

3

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

55 / 137 reitingas Energijos sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę DCC PLC

DCC plc engages in the sales, marketing, and distribution of carbon energy solutions worldwide. The company operates through DCC Energy, DCC Healthcare, and DCC Technology segments. It sells transport and commercial fuels, heating oils and related products, liquid gas, refrigerants, electricity, and natural gas; sells and installs solar panels and energy efficiency solutions; operates a network of retail forecourts on motorways and in urban areas that provides fuel and EV charging; and offers multi-fuel bunkering and value add services for small/mid-sized fleets. It also offers medical devices for use in minimally invasive surgeries and related procedures in therapy areas, such as gastroenterology and urology; markets and sells medial consumables and equipment to including GPs, community healthcare providers, retail pharmacies, and emergency services; manufactures products for health and beauty brand owners; and develops and manufactures nutritional supplements and beauty products comprising tablets, capsules, gummies, soft gels, effervescents, powders, creams and liquids. In, addition it sells Pro Tech, which bring professional technologies together to enhance audio and visual experiences; Life Tech that provides technology to make high-quality lifestyles happen; and Info Tech to make faster connections happen. The company was incorporated in 1976 and is headquartered in Dublin, Ireland.
help-icon Live chat